A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Xian-Janssen Pharmaceutical Ltd.
ClinicalTrials.gov Identifier:
NCT00350467
First received: July 7, 2006
Last updated: May 18, 2011
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Estimated Primary Completion Date: No date given